FENNEC PHARMACEUTICALS INC. — Director's Dealing 2021

Oct 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2021-10-21

Reporting Person: RALLIS CHRIS A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-21	Common Shares	M	3333	$1.50	Acquired	3333	Direct

Footnotes

F1: Represents options granted on November 18, 2011, with a $1.50 USD strike price and an expiration of November 18, 2021.